Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

X

Manasi Vaidya

14 Oct 2021

Analysis

Quest persists for ideal Covid-19 booster timelines, vaccine mixing in blood cancers

14 Oct 2021

11 Oct 2021

Analysis

Uneven Covid-19 vaccine efficacy in blood cancers mean masks to stay

11 Oct 2021

24 Sep 2021

Analysis

RSV vaccines improve on technology but contend with a post-Covid world

24 Sep 2021

22 Sep 2021

Analysis

Merck and Ridgeback’s molnupiravir rollout difficult to map in uncertain Covid-19 landscape

22 Sep 2021

06 Sep 2021

Analysis

Regulatory roundup: Akeso’s bispecific antibody moves closer to approval in China

06 Sep 2021

01 Sep 2021

Analysis

ACTIV-3: AZ Covid-19 antibody cocktail trial set to complete enrolment by end of month

01 Sep 2021

31 Aug 2021

Analysis

Regulatory roundup: Alexion ALS drug sees approval prospects plummet

31 Aug 2021

25 Aug 2021

Analysis

Gilead’s lenacapavir: HIV prospects strongest in long-acting combos with Merck’s islatravir

25 Aug 2021

24 Aug 2021

Analysis

Akebia and GSK will grapple with heightened scrutiny of HIF PHIs after roxadustat concerns

24 Aug 2021

24 Aug 2021

Analysis

Regulatory roundup: Roche’s Cotellic among cancer drugs with declining approval outlook

24 Aug 2021